Products Archive
US$ 20.77
semaglutide discontinued Hims and Ro Stopped Selling Compounded — Where to Get It Now (2026) why is semaglutide being discontinued
Description
Tirzepatide, marketed under the brand name Zepbound, is a dual agonist that targets the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors
The glucagon arm activates liver fat-burning, defends resting metabolic rate against dropping, and amplifies the heart-rate climb
A peer-reviewed Phase 2 trial reported a 24.2% mean weight reduction after 48 weeks in its highest-dose group
Some argue that GLP-1RAs may exert neuroprotective effects indirectly via systemic mechanisms, while others suggest that more brain-penetrant incretins might be required for meaningful benefit
